Janus Henderson Group PLC Global Blood Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $110 Million - $231 Million	-3,382,905 Reduced 75.54%	1,095,343 $74.6 Million
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $25.1 Million - $42.1 Million	-1,125,007 Reduced 20.08%	4,478,248 $143 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $3.08 Million - $4.27 Million	120,091 Added 2.19%	5,603,255 $194 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $19.7 Million - $31.8 Million	-789,518 Reduced 12.59%	5,483,164 $160 Million
Q3 2021 Nov 16, 2021	BUY	$25.48 - $37.34 $2.66 Million - $3.9 Million	104,532 Added 1.69%	6,272,682 $160 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $9.27 Million - $12.4 Million	285,575 Added 4.85%	6,168,150 $216 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $3.28 Million - $4.29 Million	-84,287 Reduced 1.41%	5,882,575 $240 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $20.4 Million - $34.5 Million	540,580 Added 9.96%	5,966,862 $258 Million
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $47 Million - $66.4 Million	891,029 Added 19.65%	5,426,282 $299 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $912,615 - $1.53 Million	-18,728 Reduced 0.41%	4,535,253 $286 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $64.9 Million - $136 Million	1,555,086 Added 51.86%	4,553,981 $233 Million
Q4 2019 Feb 18, 2020	BUY	$45.7 - $81.86 $25.1 Million - $45 Million	549,524 Added 22.44%	2,998,895 $238 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $760,338 - $970,919	16,766 Added 0.69%	2,449,371 $119 Million
Q2 2019 Jul 31, 2019	SELL	$52.6 - $63.29 $4.41 Million - $5.3 Million	-83,760 Reduced 3.33%	2,432,605 $128 Million
Q1 2019 Apr 30, 2019	SELL	$39.99 - $53.48 $276,050 - $369,172	-6,903 Reduced 0.27%	2,516,365 $133 Million
Q4 2018 Feb 06, 2019	SELL	$31.54 - $46.67 $23.5 Million - $34.8 Million	-744,770 Reduced 22.79%	2,523,268 $104 Million
Q3 2018 Nov 09, 2018	SELL	$38.0 - $51.1 $33.7 Million - $45.3 Million	-886,347 Reduced 21.34%	3,268,038 $124 Million
Q2 2018 Aug 10, 2018	BUY	$38.7 - $50.15 $17.5 Million - $22.7 Million	452,843 Added 12.23%	4,154,385 $188 Million
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $26.6 Million - $44.3 Million	672,760 Added 22.21%	3,701,542 $179 Million
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $47.9 Million - $73.7 Million	1,613,224 Added 113.96%	3,028,782 $119 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $10.8 Million - $13.4 Million	431,325 Added 43.82%	1,415,558 $0
Q2 2017 Aug 17, 2017	BUY	N/A	984,233	984,233 $26.9 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account